中源協和(600645.SH):2021年度預盈1.3億元-1.95億元 同比扭虧
格隆匯1月28日丨中源協和(600645.SH)公佈2021年年度業績預盈公吿,公司2021年度預計實現歸屬於上市公司股東的淨利潤為1.3億元到1.95億元,同比扭虧為盈。預計2021年度歸屬於上市公司股東扣除非經常性損益後的淨利潤為5000萬元到7500萬元。
業績預盈的主要原因:
(一)報吿期內,公司收入較2020年度相比,增加約2億元;
(二)報吿期內,公司參股的Aceso Biotech Venture Fund, L.P.及深圳盈泰泓康創業投資合夥企業(有限合夥)下屬投資公司估值增加,影響公司2021年合併利潤約7000萬元;
(三)報吿期內,公司下屬子公司SDIX LLC、OriGene Technologies,Inc的“美國PPP保障計劃貸款”經SBA批准全額豁免,影響公司2021年合併利潤1205萬元;
(四)上海執誠生物科技有限公司合併商譽存在減值跡象,預計減值金額約為1900萬元,公司已聘請專業評估機構對上海執誠合併商譽開展與減值測試相關的估值工作,最終數據需以專業評估機構所出具的評估報吿結果為確定依據。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.